Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.

Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W.

World J Gastroenterol. 2012 Aug 14;18(30):3955-61. doi: 10.3748/wjg.v18.i30.3955.

2.

Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.

Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A.

Anticancer Res. 2007 Mar-Apr;27(2):851-6.

3.

Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.

Ando T, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Sugito N, Mori R, Ogawa R, Katada T, Fujii Y.

Dis Esophagus. 2008;21(1):15-20. doi: 10.1111/j.1442-2050.2007.00700.x.

PMID:
18197934
5.

Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.

Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T.

Oncol Rep. 2006 Apr;15(4):875-82.

PMID:
16525674
6.

TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy.

Tanaka K, Saigusa S, Toiyama Y, Koike Y, Okugawa Y, Yokoe T, Inoue Y, Kobayashi M, Miki C, Kusunoki M.

J Surg Oncol. 2012 May;105(6):529-34. doi: 10.1002/jso.22123. Epub 2011 Oct 17.

PMID:
22006578
8.

Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma.

Nagasaki T, Tsuchiya T, Tagawa T, Honda S, Yamasaki N, Miyazaki T, Hidaka S, Hayashi T, Nagayasu T.

Clin Lung Cancer. 2010 Nov 1;11(6):412-22. doi: 10.3816/CLC.2010.n.053.

PMID:
21062732
9.
10.

Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.

Ijuin T, Nibu K, Doi K, Inoue H, Saitoh M, Ohtsuki N, Makino K, Amatsu M.

Acta Otolaryngol. 2007 Mar;127(3):305-11.

PMID:
17364369
11.

Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites.

Wang T, Wang L, Qian X, Yu L, Ding Y, Liu B.

Cancer Invest. 2011 Feb;29(2):130-6. doi: 10.3109/07357907.2010.535060. Epub 2011 Jan 6.

PMID:
21210725
12.

5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.

Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallbohmer D, Park S, Danenberg KD, Takasaki K, Danenberg PV.

Int J Cancer. 2006 Aug 1;119(3):522-6.

13.

Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.

Inokuchi M, Uetake H, Shirota Y, Yamada H, Tajima M, Sugihara K.

Cancer Chemother Pharmacol. 2004 May;53(5):391-6. Epub 2004 Jan 20.

PMID:
15060742
14.

Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.

Matsuyama R, Togo S, Shimizu D, Momiyama N, Ishikawa T, Ichikawa Y, Endo I, Kunisaki C, Suzuki H, Hayasizaki Y, Shimada H.

Int J Cancer. 2006 Jul 15;119(2):406-13.

15.

The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells.

Oguri T, Achiwa H, Bessho Y, Muramatsu H, Maeda H, Niimi T, Sato S, Ueda R.

Lung Cancer. 2005 Sep;49(3):345-51.

PMID:
15993511
16.
17.

Expression of 5-fluorouracil-related enzymes in lung cancer: ELISA characterizes enzyme activity and messenger RNA expression.

Tsuchida M, Yamato Y, Hashimoto T, Shinohara H, Umezu H, Yoshiya K, Koike T, Hayashi J.

Oncol Rep. 2009 Apr;21(4):1037-43.

PMID:
19288006
18.

The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma.

Yamashita T, Toida M, Kato K, Long NK, Miyazaki Y, Asaka Y, Hatakeyama D, Yonemoto K, Makita H, Kato Y, Shibata T.

Oncol Rep. 2009 Sep;22(3):501-7.

PMID:
19639195
19.

Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.

Kakimoto M, Uetake H, Osanai T, Shirota Y, Takagi Y, Takeshita E, Toriya Y, Danenberg K, Danenberg PV, Sugihara K.

Cancer Lett. 2005 Jun 1;223(1):103-11.

PMID:
15890242
20.

Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy.

Tateishi Y, Tatemoto Y, Ohno S, Morishita K, Ueta E, Yamamoto T.

Cancer Lett. 2009 Feb 18;274(2):187-93. doi: 10.1016/j.canlet.2008.09.010. Epub 2008 Nov 4.

PMID:
18986760

Supplemental Content

Support Center